IL6 and breast carcinoma: For example, therapeutic blockade of IL-6 and IL-8 in mice using Tocilizumab (a humanised monoclonal antibody against the α chain of IL-6) and Reparixin (a low-molecular-weight inhibitor of IL-8 signalling) seems to be very effective in suppressing breast cancer metastasis in experiments.